STOCK TITAN

[S-8] First Foundation Inc. Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8
Rhea-AI Filing Summary

Upstart Holdings, Inc. (UPST) has filed a Form 144 indicating a proposed insider sale under SEC Rule 144.

  • Securities to be sold: 10,957 common shares.
  • Estimated market value: US $834,683, based on the broker-quoted price at the time of filing.
  • Broker: Charles Schwab & Co., Inc., Westlake, TX.
  • Planned sale date: 08 July 2025 on the NASDAQ.
  • Securities outstanding: 95,144,858 shares; proposed sale represents roughly 0.012 % of total shares.

The shares were recently acquired on 08 July 2025 through a stock-option exercise executed via a cashless, broker-assisted transaction. The same filer sold 1,278 shares on 01 July 2025 for gross proceeds of US $85,639, signalling an ongoing liquidation of option-derived shares within the preceding three-month window.

While Form 144 filings are not binding commitments to sell, they disclose the intent and establish regulatory clearance for a potential transaction within the next 90 days. The modest size relative to Upstart’s float suggests limited direct dilution or price pressure, but investors often monitor continued insider selling for sentiment cues.

Upstart Holdings, Inc. (UPST) ha presentato un Modulo 144 che segnala una prevista vendita da parte di un insider ai sensi della Regola 144 della SEC.

  • Titoli da vendere: 10.957 azioni ordinarie.
  • Valore di mercato stimato: 834.683 USD, basato sul prezzo quotato dal broker al momento della presentazione.
  • Broker: Charles Schwab & Co., Inc., Westlake, TX.
  • Data prevista per la vendita: 8 luglio 2025 sul NASDAQ.
  • Azioni in circolazione: 95.144.858; la vendita proposta rappresenta circa lo 0,012% del totale.

Le azioni sono state recentemente acquisite l'8 luglio 2025 tramite l'esercizio di un'opzione azionaria realizzato tramite una transazione assistita dal broker e senza esborso di denaro. Lo stesso soggetto ha venduto 1.278 azioni il 1° luglio 2025 per un ricavo lordo di 85.639 USD, indicando una liquidazione in corso di azioni derivate da opzioni nell'arco degli ultimi tre mesi.

Anche se le presentazioni del Modulo 144 non costituiscono un impegno vincolante a vendere, esse divulgano l'intenzione e ottengono l'autorizzazione regolamentare per una potenziale transazione entro i successivi 90 giorni. La dimensione contenuta rispetto al flottante di Upstart suggerisce un impatto limitato su diluizione o pressione sul prezzo, ma gli investitori monitorano spesso le vendite da parte degli insider per cogliere segnali sul sentiment.

Upstart Holdings, Inc. (UPST) ha presentado un Formulario 144 que indica una propuesta de venta por parte de un insider según la Regla 144 de la SEC.

  • Valores a vender: 10,957 acciones comunes.
  • Valor estimado de mercado: 834,683 USD, basado en el precio cotizado por el corredor al momento de la presentación.
  • Corredor: Charles Schwab & Co., Inc., Westlake, TX.
  • Fecha prevista de venta: 8 de julio de 2025 en NASDAQ.
  • Acciones en circulación: 95,144,858; la venta propuesta representa aproximadamente el 0.012% del total.

Las acciones fueron recientemente adquiridas el 8 de julio de 2025 mediante el ejercicio de una opción sobre acciones ejecutada a través de una transacción asistida por corredor y sin desembolso de efectivo. El mismo declarante vendió 1,278 acciones el 1 de julio de 2025 por ingresos brutos de 85,639 USD, señalando una liquidación continua de acciones derivadas de opciones en los últimos tres meses.

Aunque las presentaciones del Formulario 144 no son compromisos vinculantes de venta, revelan la intención y establecen la autorización regulatoria para una posible transacción dentro de los próximos 90 días. El tamaño modesto en relación con el flotante de Upstart sugiere una dilución o presión de precio limitada, pero los inversores suelen vigilar las ventas continuas de insiders para obtener señales sobre el sentimiento.

Upstart Holdings, Inc. (UPST)는 SEC 규칙 144에 따른 내부자 판매 예정임을 알리는 Form 144를 제출했습니다.

  • 판매 예정 증권: 보통주 10,957주.
  • 추정 시가총액: 제출 시점의 중개인 가격을 기준으로 미화 834,683달러.
  • 중개인: Charles Schwab & Co., Inc., Westlake, TX.
  • 예정 판매일: 2025년 7월 8일, NASDAQ에서.
  • 발행 주식 수: 95,144,858주; 제안된 판매는 전체 주식의 약 0.012%에 해당.

해당 주식은 최근 2025년 7월 8일 현금 없는 중개인 지원 거래를 통해 주식 옵션 행사로 취득되었습니다. 동일 제출자는 2025년 7월 1일 1,278주를 총 85,639달러에 판매하여 최근 3개월 내 옵션으로 취득한 주식의 지속적인 매도를 시사합니다.

Form 144 제출은 판매 의무가 아니지만, 향후 90일 내 잠재 거래에 대한 의도 공개 및 규제 승인 확보를 의미합니다. Upstart의 유통 주식 대비 판매 규모가 작아 직접적인 희석이나 가격 압박은 제한적일 것으로 보이나, 투자자들은 내부자 매도 동향을 감시하여 시장 심리를 판단하는 경우가 많습니다.

Upstart Holdings, Inc. (UPST) a déposé un Formulaire 144 indiquant une vente envisagée par un initié conformément à la règle 144 de la SEC.

  • Valeurs mobilières à vendre : 10 957 actions ordinaires.
  • Valeur marchande estimée : 834 683 USD, basée sur le cours coté par le courtier au moment du dépôt.
  • Courtage : Charles Schwab & Co., Inc., Westlake, TX.
  • Date prévue de la vente : 8 juillet 2025 sur le NASDAQ.
  • Actions en circulation : 95 144 858 actions ; la vente proposée représente environ 0,012 % du total.

Les actions ont été récemment acquises le 8 juillet 2025 par l'exercice d'une option d'achat d'actions réalisée via une transaction assistée par courtier sans décaissement de fonds. Le même déclarant a vendu 1 278 actions le 1er juillet 2025 pour un produit brut de 85 639 USD, indiquant une liquidation continue d'actions issues d'options au cours des trois derniers mois.

Bien que les dépôts du formulaire 144 ne constituent pas un engagement ferme de vente, ils révèlent l'intention et obtiennent l'autorisation réglementaire pour une transaction potentielle dans les 90 jours suivants. La taille modeste par rapport au flottant d'Upstart suggère une dilution ou une pression sur le prix limitée, mais les investisseurs surveillent souvent les ventes d'initiés pour en déduire le sentiment du marché.

Upstart Holdings, Inc. (UPST) hat ein Formular 144 eingereicht, das einen geplanten Insider-Verkauf gemäß SEC-Regel 144 anzeigt.

  • Zu verkaufende Wertpapiere: 10.957 Stammaktien.
  • Geschätzter Marktwert: 834.683 US-Dollar, basierend auf dem zum Zeitpunkt der Einreichung vom Broker angegebenen Kurs.
  • Broker: Charles Schwab & Co., Inc., Westlake, TX.
  • Geplanter Verkaufstermin: 8. Juli 2025 an der NASDAQ.
  • Ausstehende Wertpapiere: 95.144.858 Aktien; der geplante Verkauf entspricht etwa 0,012 % der Gesamtaktien.

Die Aktien wurden kürzlich am 8. Juli 2025 durch Ausübung einer Aktienoption erworben, die in einer bargeldlosen, brokerunterstützten Transaktion durchgeführt wurde. Derselbe Einreicher verkaufte am 1. Juli 2025 1.278 Aktien für Bruttoerlöse von 85.639 US-Dollar, was auf eine laufende Veräußerung von aktienoptionsbasierten Anteilen innerhalb der letzten drei Monate hinweist.

Formular-144-Einreichungen sind zwar keine verbindlichen Verkaufszusagen, geben jedoch die Absicht bekannt und schaffen die regulatorische Freigabe für eine mögliche Transaktion innerhalb der nächsten 90 Tage. Die geringe Größe im Verhältnis zum Free Float von Upstart deutet auf eine begrenzte direkte Verwässerung oder Preisdruck hin, aber Investoren beobachten Insider-Verkäufe oft als Stimmungsindikator.

Positive
  • Sale represents only ~0.012 % of shares outstanding, implying negligible dilution or supply overhang.
  • Transparent regulatory filing provides investors with early notice of potential insider activity.
Negative
  • Continued insider selling (prior 1,278 shares sold on 07/01/2025) may signal reduced confidence or desire to monetise holdings.
  • Proposed sale occurs immediately after option exercise, which some investors view as opportunistic profit-taking.

Insights

TL;DR: Minor insider sale (0.012 % float) suggests limited market impact but extends a recent selling pattern.

The Form 144 reveals an intended disposal of 10,957 shares, worth roughly US $0.83 million, shortly after an option exercise. Because the amount is immaterial to the 95 million-share float, I view direct price impact as negligible. However, the filer also sold 1,278 shares a week earlier, indicating a continuation of share-monetisation. Persistent insider selling—especially soon after option conversion—can be interpreted as a lukewarm view on near-term upside, even if for tax or diversification reasons. Absence of any simultaneous insider purchases keeps the signal skewed slightly negative.

TL;DR: Filing is largely routine; scale too small to alter UPST investment thesis.

The notice merely authorises—but does not obligate—the insider to sell over the next 90 days. With a float-adjusted weight under 0.02 %, the sale should not meaningfully affect liquidity or valuation metrics. From a risk standpoint, I classify this as a low-severity event. Unless a broader trend of insider divestitures emerges or totals escalate, I would not adjust position sizing based solely on this filing.

Upstart Holdings, Inc. (UPST) ha presentato un Modulo 144 che segnala una prevista vendita da parte di un insider ai sensi della Regola 144 della SEC.

  • Titoli da vendere: 10.957 azioni ordinarie.
  • Valore di mercato stimato: 834.683 USD, basato sul prezzo quotato dal broker al momento della presentazione.
  • Broker: Charles Schwab & Co., Inc., Westlake, TX.
  • Data prevista per la vendita: 8 luglio 2025 sul NASDAQ.
  • Azioni in circolazione: 95.144.858; la vendita proposta rappresenta circa lo 0,012% del totale.

Le azioni sono state recentemente acquisite l'8 luglio 2025 tramite l'esercizio di un'opzione azionaria realizzato tramite una transazione assistita dal broker e senza esborso di denaro. Lo stesso soggetto ha venduto 1.278 azioni il 1° luglio 2025 per un ricavo lordo di 85.639 USD, indicando una liquidazione in corso di azioni derivate da opzioni nell'arco degli ultimi tre mesi.

Anche se le presentazioni del Modulo 144 non costituiscono un impegno vincolante a vendere, esse divulgano l'intenzione e ottengono l'autorizzazione regolamentare per una potenziale transazione entro i successivi 90 giorni. La dimensione contenuta rispetto al flottante di Upstart suggerisce un impatto limitato su diluizione o pressione sul prezzo, ma gli investitori monitorano spesso le vendite da parte degli insider per cogliere segnali sul sentiment.

Upstart Holdings, Inc. (UPST) ha presentado un Formulario 144 que indica una propuesta de venta por parte de un insider según la Regla 144 de la SEC.

  • Valores a vender: 10,957 acciones comunes.
  • Valor estimado de mercado: 834,683 USD, basado en el precio cotizado por el corredor al momento de la presentación.
  • Corredor: Charles Schwab & Co., Inc., Westlake, TX.
  • Fecha prevista de venta: 8 de julio de 2025 en NASDAQ.
  • Acciones en circulación: 95,144,858; la venta propuesta representa aproximadamente el 0.012% del total.

Las acciones fueron recientemente adquiridas el 8 de julio de 2025 mediante el ejercicio de una opción sobre acciones ejecutada a través de una transacción asistida por corredor y sin desembolso de efectivo. El mismo declarante vendió 1,278 acciones el 1 de julio de 2025 por ingresos brutos de 85,639 USD, señalando una liquidación continua de acciones derivadas de opciones en los últimos tres meses.

Aunque las presentaciones del Formulario 144 no son compromisos vinculantes de venta, revelan la intención y establecen la autorización regulatoria para una posible transacción dentro de los próximos 90 días. El tamaño modesto en relación con el flotante de Upstart sugiere una dilución o presión de precio limitada, pero los inversores suelen vigilar las ventas continuas de insiders para obtener señales sobre el sentimiento.

Upstart Holdings, Inc. (UPST)는 SEC 규칙 144에 따른 내부자 판매 예정임을 알리는 Form 144를 제출했습니다.

  • 판매 예정 증권: 보통주 10,957주.
  • 추정 시가총액: 제출 시점의 중개인 가격을 기준으로 미화 834,683달러.
  • 중개인: Charles Schwab & Co., Inc., Westlake, TX.
  • 예정 판매일: 2025년 7월 8일, NASDAQ에서.
  • 발행 주식 수: 95,144,858주; 제안된 판매는 전체 주식의 약 0.012%에 해당.

해당 주식은 최근 2025년 7월 8일 현금 없는 중개인 지원 거래를 통해 주식 옵션 행사로 취득되었습니다. 동일 제출자는 2025년 7월 1일 1,278주를 총 85,639달러에 판매하여 최근 3개월 내 옵션으로 취득한 주식의 지속적인 매도를 시사합니다.

Form 144 제출은 판매 의무가 아니지만, 향후 90일 내 잠재 거래에 대한 의도 공개 및 규제 승인 확보를 의미합니다. Upstart의 유통 주식 대비 판매 규모가 작아 직접적인 희석이나 가격 압박은 제한적일 것으로 보이나, 투자자들은 내부자 매도 동향을 감시하여 시장 심리를 판단하는 경우가 많습니다.

Upstart Holdings, Inc. (UPST) a déposé un Formulaire 144 indiquant une vente envisagée par un initié conformément à la règle 144 de la SEC.

  • Valeurs mobilières à vendre : 10 957 actions ordinaires.
  • Valeur marchande estimée : 834 683 USD, basée sur le cours coté par le courtier au moment du dépôt.
  • Courtage : Charles Schwab & Co., Inc., Westlake, TX.
  • Date prévue de la vente : 8 juillet 2025 sur le NASDAQ.
  • Actions en circulation : 95 144 858 actions ; la vente proposée représente environ 0,012 % du total.

Les actions ont été récemment acquises le 8 juillet 2025 par l'exercice d'une option d'achat d'actions réalisée via une transaction assistée par courtier sans décaissement de fonds. Le même déclarant a vendu 1 278 actions le 1er juillet 2025 pour un produit brut de 85 639 USD, indiquant une liquidation continue d'actions issues d'options au cours des trois derniers mois.

Bien que les dépôts du formulaire 144 ne constituent pas un engagement ferme de vente, ils révèlent l'intention et obtiennent l'autorisation réglementaire pour une transaction potentielle dans les 90 jours suivants. La taille modeste par rapport au flottant d'Upstart suggère une dilution ou une pression sur le prix limitée, mais les investisseurs surveillent souvent les ventes d'initiés pour en déduire le sentiment du marché.

Upstart Holdings, Inc. (UPST) hat ein Formular 144 eingereicht, das einen geplanten Insider-Verkauf gemäß SEC-Regel 144 anzeigt.

  • Zu verkaufende Wertpapiere: 10.957 Stammaktien.
  • Geschätzter Marktwert: 834.683 US-Dollar, basierend auf dem zum Zeitpunkt der Einreichung vom Broker angegebenen Kurs.
  • Broker: Charles Schwab & Co., Inc., Westlake, TX.
  • Geplanter Verkaufstermin: 8. Juli 2025 an der NASDAQ.
  • Ausstehende Wertpapiere: 95.144.858 Aktien; der geplante Verkauf entspricht etwa 0,012 % der Gesamtaktien.

Die Aktien wurden kürzlich am 8. Juli 2025 durch Ausübung einer Aktienoption erworben, die in einer bargeldlosen, brokerunterstützten Transaktion durchgeführt wurde. Derselbe Einreicher verkaufte am 1. Juli 2025 1.278 Aktien für Bruttoerlöse von 85.639 US-Dollar, was auf eine laufende Veräußerung von aktienoptionsbasierten Anteilen innerhalb der letzten drei Monate hinweist.

Formular-144-Einreichungen sind zwar keine verbindlichen Verkaufszusagen, geben jedoch die Absicht bekannt und schaffen die regulatorische Freigabe für eine mögliche Transaktion innerhalb der nächsten 90 Tage. Die geringe Größe im Verhältnis zum Free Float von Upstart deutet auf eine begrenzte direkte Verwässerung oder Preisdruck hin, aber Investoren beobachten Insider-Verkäufe oft als Stimmungsindikator.

 

As filed with the Securities and Exchange Commission on July 8, 2025

 

Registration No. 333-            

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

FIRST FOUNDATION INC.

(Exact name of registrant as specified in its charter)

 

Delaware   20-8639702
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)
     
5221 North O’Connor Boulevard, Suite 1375
Irving, Texas
  75039
(Address of principal executive offices)   (Zip Code)

 

First Foundation Inc. Amended and Restated 2024 Equity Incentive Plan

(Full title of plan)

 

Erica Dorsett

Executive Vice President, General Counsel

First Foundation Inc.

5221 North O’Connor Boulevard, Suite 1375

Irving, Texas

(469) 638-9636

(Name, address, including zip code, and telephone number, including area code of agent for service)

 

With copies to:

Joshua A. Dean, Esq.

Sheppard, Mullin, Richter & Hampton LLP

650 Town Center Drive, Tenth Floor

Costa Mesa, California 92626

(714) 513-5100

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer x
       
Non-accelerated filer ¨ Smaller reporting company ¨
       
    Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

 

 

 

 

 

 

Explanatory Note

 

First Foundation Inc. (the “Company”) previously filed a Registration Statement on Form S-8 (Registration No. 333-279965) registering the issuance of 1,500,000 shares of the Company’s common stock under the First Foundation Inc. 2024 Equity Incentive Plan (the “2024 Plan”). On May 29, 2025, the Company’s stockholders approved an amendment and restatement of the 2024 Plan that, among other things, increased the number of shares of the Company’s common stock that may be issued under the 2024 Plan by 2,500,000 shares.

 

Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 is being filed by the Company for the purpose of registering the issuance of an additional 2,500,000 shares of the Company’s common stock under the 2024 Plan. The content contained in the Company’s Registration Statement on Form S-8 (Registration No. 333-279965) is hereby incorporated by reference pursuant to General Instruction E, except as supplemented by the information set forth below.

 

Part I

 

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

Item 1. Plan Information.*

 

Item 2. Registrant Information and Employee Plan Annual Information.*

 

* The documents containing the information specified in Part I will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

 

Part II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

The following documents filed by the Company with the Commission are hereby incorporated by reference in this Registration Statement:

 

·      The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission on March 17, 2025, including the information specifically incorporated by reference in such Annual Report from the Company’s definitive proxy statement on Schedule 14A, filed with the Commission on April 17, 2025;

 

·      The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 9, 2025;

 

·      The Company’s Current Reports on Form 8-K filed with the Commission on February 13, 2025, May 30, 2025 and June 27, 2025 (except for any portions of such Current Reports on Form 8-K furnished pursuant to Item 2.02 and/or Item 7.01 thereof and any corresponding exhibits thereto not filed with the Commission); and

 

·      The description of the Company’s common stock contained in the registration statement on Form 8-A, filed with the Commission on May 19, 2014, as amended by the registration statement on Form 8-A/A (Amendment No. 1), filed with the Commission on October 30, 2015, as the description therein has been updated and superseded by the description of the Company’s common stock contained in Exhibit 4.2 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Commission on March 2, 2020, and any amendment or report filed for the purpose of updating such description.

 

-1-

 

 

All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, are incorporated by reference in this Registration Statement and are a part hereof from the date of filing such documents.

 

Any statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

-2-

 

 

Item 6. Indemnification of Officers and Directors.

 

Section 145 of the Delaware General Corporation Law (the “DGCL”) permits the Company to indemnify its directors, officers, employees and agents, or other persons who are or were serving at the Company’s request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (referred to as an “indemnitee”), against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlements actually and reasonably incurred by them in connection with any action, suit or proceeding brought by third parties. The indemnitee must have acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reason to believe their conduct was unlawful. In a derivative action, an action only by or in the Company’s right, indemnification may be made only for expenses actually and reasonably incurred by the indemnitee in connection with the defense or settlement of an action or suit, and only with respect to a matter as to which they shall have acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the Company. No indemnification shall be made if such person shall have been adjudged liable to the Company, unless and only to the extent that the court in which the action or suit was brought shall determine upon application that the defendant indemnitee is fairly and reasonably entitled to indemnity for such expenses despite such adjudication of liability. Section 145(g) of the DGCL also provides that the Company may maintain insurance against liabilities even if the Company would lack the power under the DGCL to indemnify against those liabilities.

 

Article VI of the Company’s Bylaws provides that the Company will indemnify, to the fullest extent permitted by the DGCL, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative, arbitrative, investigative or other (a “Proceeding”), other than an action by or in the Company’s right, by reason of the fact that such person is or was a director or officer of the Company, or while such person is or was a director or officer of the Company, is or was serving at the Company’s request as a director, officer, employee, member, manager, trustee or agent of another corporation, limited liability company, partnership, joint venture, trust, nonprofit entity or other enterprise, including service with respect to employee benefit plans, against expenses (including attorneys’ fees), damages, losses, liabilities, judgments, fines, penalties, ERISA excise taxes, amounts paid or payable in settlement, any federal, state, local or foreign taxes, and all other charges paid or payable by such person in connection with the defense or settlement of such Proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the Company’s best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful.

 

The Company’s Bylaws further state that this indemnification shall not be deemed exclusive of any other rights to which the indemnified person may be entitled, and shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of that person.

 

Article VIII of the Company’s Certificate of Incorporation includes provisions regarding indemnification of directors and officers of the Company which are similar to those contained in Article VI of the Company’s Bylaws.

 

The Company has entered into indemnification agreements with certain of its directors and executive officers. Those indemnification agreements require that the Company, among other things, (i) indemnify its directors and officers against certain liabilities that may arise by reason of their status or service as directors or officers (other than liabilities arising from actions not taken in good faith or in a manner the indemnitee believed to be opposed to the Company’s best interests), (ii) advance the expenses such directors or executive officers may incur as a result of or in connection with the defense of any proceeding brought against them as to which they could be indemnified, subject to an undertaking by the indemnified party to repay such advances if it is ultimately determined that he or she is not entitled to indemnification, and (iii) obtain officers’ & directors’ liability insurance if available on reasonable terms.

 

The Company maintains standard policies of insurance under which coverage is provided (a) to directors and officers of the Company against loss arising from claims made by reason of breach of duty or other wrongful act, and (b) to the Company with respect to payments which may be made by it to such officers and directors pursuant to the above indemnification provision or otherwise as a matter of law.

 

-3-

 

 

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to the registrant’s directors, officers or controlling persons pursuant to the foregoing provisions, the Company has been informed that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In addition, indemnification for violations of state securities laws may be limited by applicable laws.

 

Item 8. Exhibits.

 

The following documents are filed as exhibits to this Registration Statement:

 

Exhibit   Description
4.1   Certificate of Incorporation of First Foundation Inc. (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed on October 29, 2015).
     
4.2   Certificate of Amendment to Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on October 3, 2024).
     
4.3   Certificate of Designations for Series A Noncumulative Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on July 9, 2024).
     
4.4   Certificate of Designations for Series B Noncumulative Convertible Preferred Stock (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed on July 9, 2024).
     
4.5   Certificate of Designations for Series C NVCE Stock (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K, filed on July 9, 2024).
     
4.6   Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on February 27, 2024).
     
5.1   Opinion of Sheppard Mullin Richter & Hampton, LLP.
     
10.1   First Foundation Inc. Amended and Restated 2024 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the Commission on May 30, 2025).
     
23.1   Consent of Eide Bailly LLP.
     
23.2   Consent of Crowe, LLP.
     
23.3   Consent of Sheppard Mullin Richter & Hampton, LLP (included in Exhibit 5.1).
     
24   Power of Attorney (included in signature page).
     
107   Calculation of Fee Table

 

-4-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irving, Texas, on July 8, 2025.

 

  FIRST FOUNDATION INC.
     
  By /s/ THOMAS C. SHAFER
    Thomas C. Shafer
    Chief Executive Officer

 

POWER OF ATTORNEY

 

The officers and directors of First Foundation Inc. whose signatures appear below hereby constitute and appoint Thomas C. Shafer and James Britton, and each of them, their true and lawful attorneys and agents, with full power of substitution, each with power to act alone, to sign and execute on behalf of the undersigned any amendment or amendments to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each of said attorneys-in-fact and agents full power and authority to do everything necessary to accomplish the foregoing, as fully to all intents and purposes as he or she might or could do in person, and each of the undersigned does hereby ratify and confirm all that each of said attorneys and agents, or their substitutes, shall do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons on behalf of the registrant in the capacities and on the date indicated.

 

-5-

 

 

SIGNATURE   TITLE   DATE
         
/s/ THOMAS C. SHAFER   Chief Executive Officer and Director   July 8, 2025
Thomas C. Shafer   (Principal Executive Officer)  
         
/s/ JAMES BRITTON   Chief Financial Officer   July 8, 2025
James Britton   (Principal Financial and Accounting Officer)  
         
/s/ MAX BRIGGS   Chairman and Director   July 8, 2025
Max Briggs    
         
/s/ SIMONE LAGOMARSINO   Director   July 8, 2025
Simone Lagomarsino    
         
/s/ JACOB P. SONENSHINE   Director   July 8, 2025
Jacob P. Sonenshine    
         
/s/ MITCHELL M. ROSENBERG   Director   July 8, 2025
Mitchell M. Rosenberg    
         
/s/ ELIZABETH A. PAGLIARINI   Director   July 8, 2025
Elizabeth A. Pagliarini    
         
/s/ SAM EDELSON   Director   July 8, 2025
Sam Edelson    
         
/s/HENCHY R. ENDEN   Director   July 8, 2025
Henchy R. Enden    
         
/s/ BENJAMIN MACKOVAK   Director   July 8, 2025
Benjamin Mackovak    
         
/s/ C. ALLEN PARKER   Director   July 8, 2025
C. Allen Parker    

 

-6-

 

FAQ

What does the UPST Form 144 filing disclose?

It reveals an intent to sell 10,957 common shares of Upstart Holdings, worth about $834,683.

When is the proposed sale of Upstart (UPST) shares?

The approximate sale date listed is July 8, 2025 on the NASDAQ.

How large is the planned insider sale relative to shares outstanding?

The sale equals roughly 0.012 % of the 95.1 million shares outstanding.

Who is selling the shares according to the filing?

The seller named is Sukhinder Singh Cassidy, acting for her own account.

Were there recent sales by the same insider?

Yes, 1,278 shares were sold on July 1, 2025 for $85,639 in gross proceeds.

Does a Form 144 guarantee the shares will be sold?

No. It authorises potential sales within 90 days but does not obligate the insider to complete them.
First Foundation

NYSE:FFWM

FFWM Rankings

FFWM Latest News

FFWM Latest SEC Filings

FFWM Stock Data

461.36M
77.50M
6.78%
84.44%
3.15%
Banks - Regional
State Commercial Banks
Link
United States
IRVINE